SUVRETTA CAPITAL MANAGEMENT, LLC - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 39 filers reported holding ENTRADA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
SUVRETTA CAPITAL MANAGEMENT, LLC ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,291,000
+29.7%
106,0000.0%0.05%
+63.3%
Q1 2022$995,000
-45.2%
106,0000.0%0.03%
-14.3%
Q4 2021$1,815,000106,0000.04%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,425,784$75,769,00016.37%
5AM Venture Management, LLC 4,408,379$75,471,00014.16%
72 Investment Holdings, LLC 509,024$8,714,0007.73%
TCG Crossover Management, LLC 663,694$11,362,0005.32%
Redmile Group, LLC 1,954,420$33,460,0000.76%
StepStone Group LP 761,277$13,033,0000.74%
Baker Brothers Advisors 4,704,419$80,540,0000.39%
Avidity Partners Management LP 255,000$4,366,0000.09%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,798,0000.04%
SUVRETTA CAPITAL MANAGEMENT, LLC 106,000$1,815,0000.04%
View complete list of ENTRADA THERAPEUTICS INC shareholders